Bowen Li

发表

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis

X. Le, N. Liang, Yadong Wang, 2022, Cancers.

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation

Yang Song, N. Liang, Yang Song, 2023, Frontiers in Bioengineering and Biotechnology.

Rare cystic lymphangioma in the chest wall of an adult patient: A case report and comprehensive review of the literature

D. Chang, Yong Cui, Chunquan Liu, 2020, Thoracic cancer.

Mathematical prediction model of computed tomography signs is superior to intraoperative frozen section in the diagnosis of ground‐glass nodular invasive adenocarcinoma of the lung

F. Tian, Yong Cui, Jizheng Tang, 2021, Thoracic cancer.

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report

N. Liang, Z. Bing, Yadong Wang, 2021, Frontiers in Pharmacology.

Pulmonary cryptococcosis mimicking lung cancer: 3 case report

Qingtao Zhao, Wenfei Xue, Zhifei Xin, 2022, International journal of surgery case reports.

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer

Li Zhang, Lei Cao, W. Lim, 2021, Translational lung cancer research.

Dual targeting PET tracer [68Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study

Zhaohui Zhu, N. Liang, Xiaoyuan Chen, 2023, Theranostics.

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer

Lei Cao, Xue Wu, Q. Ou, 2022, Clinical and translational medicine.

Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two‐sample Mendelian randomization study

N. Liang, Bowen Li, C. Guo, 2024, Thoracic cancer.

Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer

N. Liang, Yang Song, Z. Bing, 2024, Cancer immunology, immunotherapy : CII.

Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

P. Christopoulos, N. Liang, Yadong Wang, 2023, Translational lung cancer research.